Quarterly Performance and Key Developments The company's results fell short of analyst estimates, both on non-GAAP adjusted earnings and revenue. Earnings per share (non-GAAP) were 6.0% below consensus, and Revenue (Non-GAAP) missed analyst estimates by approximately $5.8 billion. Net income (GAAP) declined by nearly 23% year-over-year, with profitability pressured by several factors. Segment results showed a clear divergence. In Group Benefits -- which covers employer life and health insurance products -- ...

Core Insights - MetLife reported $17.92 billion in revenue for Q2 2025, a year-over-year decline of 4.1%, with EPS of $2.02 compared to $2.28 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $18.39 billion, resulting in a surprise of -2.58%, while the EPS also missed the consensus estimate of $2.19 by -7.76% [1] Financial Performance Metrics - Adjusted Revenue from EMEA for Universal life and investment-type product policy fees was $84 million, exceeding the average estimate of $79.75 million, marking a +9.1% year-over-year change [4] - Adjusted Revenue from Corporate & other for Premiums was $8 million, below the average estimate of $8.73 million, reflecting a -46.7% year-over-year decline [4] - Adjusted Revenue from EMEA for Other Revenues was $9 million, surpassing the estimated $8.44 million, showing a +12.5% year-over-year increase [4] - Adjusted Revenue from Corporate & other for Other Revenues was $118 million, exceeding the average estimate of $100.33 million, representing a +21.7% year-over-year change [4] - Revenue from Premiums was $10.81 billion, below the five-analyst average estimate of $11.29 billion, indicating a -7% year-over-year decline [4] - Revenue from Other Revenues was $679 million, slightly above the estimated $656.89 million, reflecting a +6.4% year-over-year increase [4] - Revenue from Universal life and investment-type product policy fees was $1.26 billion, slightly below the average estimate of $1.28 billion, showing a -1.7% year-over-year decline [4] - Net investment income was reported at $5.66 billion, exceeding the estimated $5.13 billion, marking an +8.8% year-over-year increase [4] - Adjusted Revenue from Retirement & Income Solutions for Premiums was $1.21 billion, significantly below the average estimate of $1.79 billion, reflecting a -50.6% year-over-year decline [4] - Adjusted Revenue from Retirement & Income Solutions for Universal life and investment-type product policy fees was $85 million, slightly below the average estimate of $90.7 million, showing a +16.4% year-over-year increase [4] - Adjusted Revenue from Retirement & Income Solutions for Net investment income was $2.15 billion, matching the average estimate, with a +1.3% year-over-year change [4] - Adjusted Revenue from Retirement & Income Solutions for Other Revenues was $60 million, slightly above the estimated $59.67 million, reflecting a -1.6% year-over-year decline [4] Stock Performance - MetLife's shares have returned -6% over the past month, contrasting with the Zacks S&P 500 composite's +0.5% change, indicating potential underperformance in the near term [3]

MetLife (MET) came out with quarterly earnings of $2.02 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.28 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of -7.76%. A quarter ago, it was expected that this insurer would post earnings of $1.99 per share when it actually produced earnings of $1.96, delivering a surprise of -1.51%. Over the last four quarters, the company has no ...

| METLIFE | | | --- | --- | | TABLE OF CONTENTS | | | GAAP CONSOLIDATED STATEMENTS OF OPERATIONS | 2 | | CORPORATE OVERVIEW | 3 | | KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS | 5 | | EXPENSE DETAIL AND RATIOS | 7 | | GAAP CONSOLIDATED BALANCE SHEETS | 8 | | SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | 9 | | Group Benefits | | | Statements of Adjusted Earnings Available to Common Shareholders | 10 | | Other Expenses by Major Category; and Other Information | 11 | | RIS | | | Statements of ...

Core Insights - MetLife, Inc. is scheduled to report its second-quarter 2025 results on August 6, with earnings estimated at $2.19 per share and revenues at $18.4 billion [1] Earnings Estimates - The earnings estimate for the second quarter has improved over the past 30 days, but it reflects a year-over-year decline of 4%, while revenues are expected to decline by 1.5% year-over-year [2] - For the current year, MetLife's revenue estimate stands at $74.8 billion, indicating a 2.4% year-over-year increase, and the EPS estimate is $8.96, suggesting a 10.5% increase year-over-year [3] Earnings Prediction Model - The current model does not predict an earnings beat for MetLife, as it has an Earnings ESP of +0.67% and a Zacks Rank of 4 (Sell) [4] Factors Influencing Q2 Results - Rising adjusted group benefits revenues are expected to positively impact MetLife's second-quarter results, with significant contributions from operations in Asia and Latin America [5] - The Zacks Consensus Estimate for total adjusted group benefits suggests a 2.9% increase year-over-year, driven by improved profits from Asia and Latin America [6] - However, rising costs and a projected 1.4% decline in investment income may offset profit growth [6][8] Regional Performance - The Asia segment is likely to benefit from improved underwriting and variable investment income, while the Latin America business is expected to see growth from higher volumes, with adjusted earnings from Latin America projected to grow by 0.4% year-over-year [7]

Company Overview - MetLife (NYSE:MET) is expected to announce earnings on August 6, 2025, with projected earnings of approximately $2.16 per share, slightly lower than the previous year, and revenues around $18.50 billion, reflecting a decline of about 1% year-over-year [2] - The company has a current market capitalization of $53 billion, with total revenue for the past twelve months at $72 billion and net income reported at $4.5 billion [2] Earnings Performance - In the last quarter, MetLife experienced increased life underwriting margins, growth in volume, and variable investment income, although these were partially offset by negative impacts from foreign currency and lower recurring interest margins [2] - Historical data indicates that over the past five years, MetLife had 20 earnings data points with 8 positive and 12 negative one-day (1D) returns, resulting in positive 1D returns occurring roughly 40% of the time [5] - The median of the 8 positive returns was 2.2%, while the median of the 12 negative returns was -1.8% [5] Correlation Analysis - A strategy to analyze the correlation between short-term and medium-term returns following earnings can be effective, particularly if the correlation is strong [6] - Correlation data indicates that the relationship between 1D post-earnings returns and subsequent 5D returns can guide trading decisions [6][7] - The performance of peers can also impact MetLife's stock reaction following earnings, with historical data showing the influence of peer stock performance on MetLife's post-earnings returns [7][8]

Analysts on Wall Street project that MetLife (MET) will announce quarterly earnings of $2.19 per share in its forthcoming report, representing a decline of 4% year over year. Revenues are projected to reach $18.39 billion, declining 1.5% from the same quarter last year.The current level reflects a downward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over thi ...

Group 1 - The article suggests considering preferred shares issued by MetLife (NYSE: MET) in a "higher for longer" interest rate environment, indicating a potential investment opportunity [1] - The investment group European Small Cap Ideas focuses on high-quality small-cap investment opportunities in Europe, emphasizing capital gains and dividend income [1] - The group offers two model portfolios: the European Small Cap Ideas portfolio and the European REIT Portfolio, along with weekly updates and educational content [1] Group 2 - The analyst has a beneficial long position in the shares of MET.PR.A, indicating confidence in the investment [1] - There is a mention of the possibility of writing put options on MET, although it is unlikely to occur in the immediate future [2]

Market Performance - The US stock market saw significant gains on July 23, with the Dow Jones Industrial Average rising by 507.85 points, or 1.14%, closing at 45010.29 points. The Nasdaq Composite increased by 127.33 points, or 0.61%, closing at 21020.02 points, marking its first close above the 21000-point threshold. The S&P 500 index rose by 49.29 points, or 0.78%, closing at 6358.91 points [1][3][4]. Trade Agreements - President Trump announced a trade agreement between the US and Japan, which has heightened market expectations for further trade agreements before the August 1 tariff deadline. The agreement includes a reduction of the reciprocal tariff rate from 25% to 15% and Japan's commitment to invest $550 billion in the US [2][6][7]. Sector Performance - In the S&P 500, nine out of eleven sectors experienced gains, with the healthcare and industrial sectors leading with increases of 2.03% and 1.75%, respectively. The utilities and consumer staples sectors saw declines of 0.79% and 0.07% [8]. - Major technology stocks mostly rose, with AMD increasing over 3%, and other companies like NVIDIA, Boeing, and TSMC rising over 2%. Financial stocks also saw gains, with Mizuho Financial up over 6% and UBS Group up over 3% [8]. Chinese Stocks - The Nasdaq Golden Dragon China Index rose by 0.75%, with notable increases in stocks such as iQIYI, which rose over 4%, and Tiger Brokers, which increased over 3%. However, some stocks like NIO and Li Auto saw declines of over 1% [9].

美国银行全球研究将 大都会人寿保险目标价格从94美元上调至102美元。 ...